Analyzing Kenvue (NYSE:KVUE) and Reborn Coffee (NASDAQ:REBN)

Kenvue (NYSE:KVUE) and Reborn Coffee (NASDAQ:REBN) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Kenvue and Reborn Coffee, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kenvue	0	12	3	0	2.20
Reborn Coffee	1	0	0	0	1.00

Kenvue currently has a consensus target price of $19.58, indicating a potential upside of 7.99%. Given Kenvue’s stronger consensus rating and higher probable upside, analysts clearly believe Kenvue is more favorable than Reborn Coffee.

Volatility & Risk

Kenvue has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, Reborn Coffee has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500.

Profitability

This table compares Kenvue and Reborn Coffee’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kenvue	9.72%	19.72%	7.72%
Reborn Coffee	-191.48%	-995.56%	-170.77%

Institutional & Insider Ownership

97.6% of Kenvue shares are held by institutional investors. Comparatively, 1.8% of Reborn Coffee shares are held by institutional investors. 0.2% of Kenvue shares are held by insiders. Comparatively, 24.0% of Reborn Coffee shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Kenvue and Reborn Coffee”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kenvue	$15.12 billion	2.30	$1.47 billion	$0.77	23.55
Reborn Coffee	$5.93 million	1.97	-$4.81 million	($2.56)	-0.76

Kenvue has higher revenue and earnings than Reborn Coffee. Reborn Coffee is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks.

Summary

Kenvue beats Reborn Coffee on 12 of the 14 factors compared between the two stocks.

About Kenvue

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

About Reborn Coffee

Reborn Coffee, Inc., through its subsidiaries, operates and franchises retail locations, kiosks, and cafes that focus on serving specialty-roasted coffee in California. It purchases, roasts, and sells coffee, tea and other beverages, and various food items. It offers products in various form factors, such as whole bean roasted coffee bags, single-serve drip bags, and pour over packs. The company also offers its products online. Reborn Coffee, Inc. was founded in 2014 and is headquartered in Brea, California.